Tesla (TSLA) shares are down about 15% in the last month. However, over the last year or so, a modest pullback like this has signaled a cooling off before the next leg up for TSLA stock. So is Tesla fading … or is it actually a good deal right now? First, it’s important to acknowledge […]
Sure, Pandora is still up an impressive 120% the last 12 months despite a deep sell-off in March. But to me, that’s a sign that you still have time to take the money and run.
Breaking the bank
Reading between the lines, it’s clear Citigroup won’t ask for an increased buyback or dividend plan again anytime soon. You can understand why Citi is tanking.
If you care what the “smart money” is buying, check out this report of what’s hot among the 50 biggest hedge funds.
Panera may be able to reverse course if it can spark interest again with a blowout report like Chipotle did… But given the company’s reluctance to give guidance and the rather downbeat predictions for earnings and margins, I wouldn’t hold your breath.
FB stock is up 16% year-to-date despite some high-priced or downright wacky deals. Investors have little hope of short-term payoff from any of these efforts.
Show me the money
Box has racked up over $360 million in accumulated losses, with no profits in sight and with tough competition from both small and large players in the space. When this money-losing cloud computing stock goes public, steer clear.
sun rises in the east
Trying to time the market or pick short-term winners? Well, maybe then China isn’t a wise bet. But long-term, diversified investors should consider adding slowly and responsibly to their emerging market exposure right now despite China fears.
Volatility is the norm in biotech stocks. But do recent moves to the downside mean that more pain is to come in biotechnology investments, or that investors should buy the dip?
In addition to rethinking its mobile strategy and corporate leadership, Microsoft has a 2.8% dividend yield, $83 billion in cash and a will to survive. So don’t bet against Microsoft.